FindTrial
Sign In

WAROTEMAE 2018 Study

WAROTEMAE 2018 Study - WAROTEMAE2018

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000034861
Enrollment
60
Registered
2018-11-12
Start date
2018-11-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer patients

Interventions

Presence of opportunities for &quot
laughter&quot
by rakugo and comic characters once every 10 days (2 times in total) Absence of opportunities for &quot
by rakugo and comic characters

Sponsors

Osaka International Cancer Institute
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Diagnosed with cancer 2. Age 40-65 years old 3. Performance status ECOG 0-1

Exclusion criteria

Exclusion criteria: 1. Incomprehension to questionnaires 2. Illiterate 3. Lack of continuity

Design outcomes

Primary

MeasureTime frame
Immune function—

Secondary

MeasureTime frame
QOL indicator—

Countries

Japan

Contacts

Public ContactIsao Miyashiro

Osaka International Cancer Institute Cancer Control Center

miyashir@biken.osaka-u.ac.jp+81-6-6945-1181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026